Ixodes Overview

  • Founded
  • 2007
  • Status
  • Private
  • Employees
  • 2
  • Latest Deal Type
  • 2ndary - Private

Ixodes General Information


Developer of pharmaceutical products designed to treat tick-borne diseases. The company's products include therapeutic creams which are used as a preventative treatment for tick-borne borreliosis bacteria, as well as used as protection for Lyme disease, enabling patients to get rid of tick and Lyme borne diseases in a hassle-free manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Geissacher 10
  • 8126 Zumikon
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ixodes Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 000.00 Completed Generating Revenue
2. Early Stage VC 15-Jun-2012 00.000 000.00 000.00 Completed Generating Revenue
1. Early Stage VC 24-Feb-2011 $16.6M $16.6M 000.00 Completed Generating Revenue
To view Ixodes’s complete valuation and funding history, request access »

Ixodes Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
To view Ixodes’s complete cap table history, request access »

Ixodes Executive Team (3)

Name Title Board Seat Contact Info
Gustave Huber MD Co-Inventor, Chief Executive Officer, Board Member and Chemist
Luzi Von Bidder Chief Financial Officer, Board Member and Economist
You’re viewing 2 of 3 executive team members. Get the full list »

Ixodes Board Members (4)

Name Representing Role Since
Eric Menott Self Board Member 000 0000
Lorenz Werner Self Board Member 000 0000
Yonca Even Self Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Ixodes Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial